BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1394176)

  • 1. The emerging epidemic of non-Hodgkin's lymphoma: current knowledge regarding etiological factors. Time trends and pathological classification: a summary.
    Obrams GI; O'Conor G
    Cancer Res; 1992 Oct; 52(19 Suppl):5570s. PubMed ID: 1394176
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathological classification of non-Hodgkin's lymphoma for epidemiological studies.
    Weisenburger DD
    Cancer Res; 1992 Oct; 52(19 Suppl):5456s-5462s; discussion 5462s-5464s. PubMed ID: 1394154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emerging epidemic of non-Hodgkin's lymphoma: current knowledge regarding etiological factors. Research directions and general discussion: a summary.
    Mueller NE; Fraumeni JF
    Cancer Res; 1992 Oct; 52(19 Suppl):5571s. PubMed ID: 1394177
    [No Abstract]   [Full Text] [Related]  

  • 4. Conclusion/perspective II--National Cancer Institute Workshop on the emerging epidemic of non-Hodgkin's lymphoma: current knowledge regarding etiological factors.
    Correa P
    Cancer Res; 1992 Oct; 52(19 Suppl):5574s. PubMed ID: 1394180
    [No Abstract]   [Full Text] [Related]  

  • 5. An epidemic of non-Hodgkin's lymphoma: comments on time trends, possible etiologies, and the role of pathology.
    Weisenburger DD
    Mod Pathol; 1992 Sep; 5(5):481-2. PubMed ID: 1344808
    [No Abstract]   [Full Text] [Related]  

  • 6. Conclusion/perspective I--National Cancer Institute Workshop on the emerging epidemic of non-Hodgkin's lymphoma: current knowledge regarding etiological factors.
    Essex M
    Cancer Res; 1992 Oct; 52(19 Suppl):5573s. PubMed ID: 1394179
    [No Abstract]   [Full Text] [Related]  

  • 7. The emerging epidemic of non-Hodgkin's lymphoma: current knowledge regarding etiological factors.
    Levine PH; Hoover R
    Cancer Epidemiol Biomarkers Prev; 1992; 1(6):515-7. PubMed ID: 1363833
    [No Abstract]   [Full Text] [Related]  

  • 8. The emerging epidemic of non-Hodgkin's lymphoma: current knowledge regarding etiological factors. Molecular and immunoregulatory mechanisms: a summary.
    Potter M
    Cancer Res; 1992 Oct; 52(19 Suppl):5572s. PubMed ID: 1394178
    [No Abstract]   [Full Text] [Related]  

  • 9. [Epidemiology of non-Hodgkin's lymphoma: recent data].
    Chassagne-Clément C; Blay JY; Treilleux I; Sebban C; Bergeron C; Biron P; Philip T
    Bull Cancer; 1999 Jun; 86(6):529-36. PubMed ID: 10417426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Menstrual and reproductive factors and risk of non-Hodgkin's lymphoma among Connecticut women.
    Zhang Y; Holford TR; Leaderer B; Boyle P; Zahm SH; Zhang B; Zou K; Morton LM; Owens PH; Flynn S; Tallini G; Zheng T
    Am J Epidemiol; 2004 Oct; 160(8):766-73. PubMed ID: 15466499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Hodgkin's lymphoma in an Asian population: 1968-1992 time trends and ethnic differences in Singapore.
    Seow A; Lee J; Sng I; Fong CM; Lee HP
    Cancer; 1996 May; 77(9):1899-904. PubMed ID: 8646691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-Hodgkin's lymphoma. Understanding the disease.
    Rahr VA; Tucker R
    Cancer Nurs; 1990 Feb; 13(1):56-61. PubMed ID: 2407340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-Hodgkin's lymphomas in Alexandria, Egypt; incidence rates and trend study (1995-2004).
    Abdel-Fattah MM; Yassine OG
    Eur J Cancer Prev; 2007 Oct; 16(5):479-85. PubMed ID: 17923821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Non-Hodgkin's lymphoma: morphologic, immunologic and cytogenetic classification].
    Ristić S; Jovanović V; Ristić S; Radojković M
    Srp Arh Celok Lek; 1996; 124(9-10):276-82. PubMed ID: 9102863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hodgkin's and non-Hodgkin's lymphomas.
    Hartge P; Devesa SS; Fraumeni JF
    Cancer Surv; 1994; 19-20():423-53. PubMed ID: 7534635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma.
    Ko YH; Kim CW; Park CS; Jang HK; Lee SS; Kim SH; Ree HJ; Lee JD; Kim SW; Huh JR
    Cancer; 1998 Aug; 83(4):806-12. PubMed ID: 9708949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of non-Hodgkin's lymphoma in Sweden, Denmark, and Finland from 1960 through 2003: an epidemic that was.
    Sandin S; Hjalgrim H; Glimelius B; Rostgaard K; Pukkala E; Askling J
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1295-300. PubMed ID: 16835326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The therapy of non-Hodgkin's lymphomas. Introduction and overview.
    Vose JM; Bierman PJ; Weisenburger DD; Armitage JO
    Hematol Oncol Clin North Am; 1991 Oct; 5(5):845-52. PubMed ID: 1938757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The epidemiology of non-Hodgkin's lymphoma.
    Kirsner RS; Federman DG
    Conn Med; 1996 Oct; 60(10):579-82. PubMed ID: 8952129
    [No Abstract]   [Full Text] [Related]  

  • 20. [Staging classification of malignant lymphoma].
    Takagi T
    Gan To Kagaku Ryoho; 1998 Aug; 25(10):1619-22. PubMed ID: 9725059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.